tiprankstipranks
Trending News
More News >
Advertisement

PBE ETF Price & Analysis

Compare

PBE ETF Chart & Stats

ETF Overview

Invesco Dynamic Biotechnology & Genome ETF

The Invesco Dynamic Biotechnology & Genome ETF (PBE) is a specialized exchange-traded fund that offers investors a targeted opportunity to engage with the cutting-edge biotechnology sector within the broader health care industry. This ETF is meticulously designed to capture the growth potential of companies at the forefront of biotechnological innovation and genomic research, an area that is transforming the future of medicine and therapeutics. By investing in PBE, stakeholders gain exposure to a dynamic portfolio of firms that are pioneering advancements in genetic engineering, molecular biology, and biopharmaceutical development. With a focus on both established leaders and emerging innovators in the biotechnology niche, PBE provides a balanced approach to tapping into the sector's rapid growth and scientific breakthroughs. Ideal for those looking to leverage sector-specific growth trends, this ETF stands out for its strategic emphasis on companies that are shaping the future of healthcare solutions, making it a compelling choice for forward-thinking investors.

Invesco Dynamic Biotechnology & Genome ETF (PBE) Fund Flow Chart

Invesco Dynamic Biotechnology & Genome ETF (PBE) 1 year Net Flows: -$31M

PBE ETF FAQ

What was PBE’s price range in the past 12 months?
PBE lowest ETF price was $54.52 and its highest was $72.84 in the past 12 months.
    What is the AUM of PBE?
    As of Jul 11, 2025 The AUM of PBE is 233.59M.
      Is PBE overvalued?
      According to Wall Street analysts PBE’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does PBE pay dividends?
        PBE does not currently pay dividends.
        How many shares outstanding does PBE have?
        Currently, no data Available
        Which hedge fund is a major shareholder of PBE?
        Currently, no hedge funds are holding shares in PBE

        PBE ETF Smart Score

        For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

        Top 10 Holdings

        Name
        Weight %
        Illumina
        5.57%
        Royalty Pharma PLC
        5.17%
        Alnylam Pharmaceuticals
        5.08%
        Amgen Inc
        4.96%
        Vertex Pharmaceuticals Inc.
        4.94%
        Gilead Sciences
        4.79%
        Biomarin Pharmaceutical Inc.
        4.68%
        United Therapeutics Corp.
        4.41%
        Anavex Life Sciences
        3.96%
        Blueprint Medicines Corp.
        3.29%
        Total46.86%
        See All Holdings
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Advertisement